| Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets K Sehgal, R Das, L Zhang, R Verma, Y Deng, M Kocoglu, J Vasquez, ... Blood, The Journal of the American Society of Hematology 125 (26), 4042-4051, 2015 | 127 | 2015 |
| ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells CS Boddupalli, S Nair, SM Gray, HN Nowyhed, R Verma, JA Gibson, ... The Journal of clinical investigation 126 (10), 3905-3916, 2016 | 105 | 2016 |
| Beliefs and barriers to medication use in parents of Latino children with asthma EL McQuaid, J Vasquez, G Canino, GK Fritz, AN Ortega, A Colon, ... Pediatric pulmonology 44 (9), 892-898, 2009 | 85 | 2009 |
| Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma MH Robinson, J Vasquez, A Kaushal, TJ MacDonald, JEV Vega, ... Journal for immunotherapy of cancer 8 (2), 2020 | 43 | 2020 |
| SOX2 immunity and tissue resident memory in children and young adults with glioma JC Vasquez, A Huttner, L Zhang, A Marks, A Chan, JM Baehring, ... Journal of neuro-oncology 134 (1), 41-53, 2017 | 33 | 2017 |
| Risk-associated alterations in marrow T cells in pediatric leukemia JK Bailur, SS McCachren, K Pendleton, JC Vasquez, HS Lim, A Duffy, ... JCI insight 5 (16), 2020 | 24 | 2020 |
| Ethnic differences in somatic symptom reporting in children with asthma and their parents JC Vasquez, GK Fritz, SJ Kopel, R Seifer, EL McQuaid, G Canino Journal of the American Academy of Child & Adolescent Psychiatry 48 (8), 855-863, 2009 | 23 | 2009 |
| TOP1-DNA trapping by exatecan and combination therapy with ATR inhibitor U Jo, Y Murai, KK Agama, Y Sun, LK Saha, X Yang, Y Arakawa, S Gayle, ... Molecular Cancer Therapeutics, 2022 | 22 | 2022 |
| Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors A Sule, J Van Doorn, RK Sundaram, S Ganesa, JC Vasquez, RS Bindra NAR cancer 3 (2), zcab018, 2021 | 21 | 2021 |
| Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy D Ueno, JC Vasquez, A Sule, J Liang, J van Doorn, R Sundaram, ... Oncotarget 13, 1054-1067, 2022 | 8 | 2022 |
| Antigen-independent tumor targeting by CBX-12 (alphalex™–exatecan) induces long-term antitumor immunity S Gayle, T Paradis, K Jones, J Vasquez, VM Paralkar Immunotherapy 14 (18), 1467-1480, 2022 | 3 | 2022 |
| Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma CS Hong, JC Vasquez, AJ Kundishora, AA Elsamadicy, JM Beckta, A Sule, ... NPJ Genomic Medicine 5 (1), 1-7, 2020 | 3 | 2020 |
| Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report KO McNerney, JC Vasquez, MW Kent, JM McNamara Journal of pediatric hematology/oncology 39 (8), e454-e455, 2017 | 3 | 2017 |
| Metastatic and multiply relapsed SDH-deficient GIST and paraganglioma displays clinical response to combined poly ADP-ribose polymerase inhibition and temozolomide. C Singh, RS Bindra, PM Glazer, JC Vasquez, F Pashankar Pediatric Blood & Cancer, e30020-e30020, 2022 | 2 | 2022 |
| Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor S Malik, SP Pradeep, V Kumar, Y Xiao, Y Deng, R Fan, JC Vasquez, ... Cell Reports Medicine 5 (1), 2024 | 1 | 2024 |
| Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group JC Vasquez, LY Luo, SM Hiniker, DS Rhee, R Dasgupta, S Chen, ... Pediatric Blood & Cancer, e30293, 2023 | 1 | 2023 |
| The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors SE Gueble, JC Vasquez, RS Bindra Current Treatment Options in Oncology, 1-24, 2022 | 1 | 2022 |
| SOX2 as a target for immunotherapy of pediatric gliomas. J Vasquez, A Huttner, L Zhang, A Marks, A Chan, JM Baehring, K Kahle, ... Journal of Clinical Oncology 35 (15_suppl), e22012-e22012, 2017 | 1 | 2017 |
| Comparison of pomalidomide dosing strategies in lenalidomide-refractory myeloma: Impact on clinical outcome, immune activation and cereblon targets R Das, K Sehgal, L Zhang, R Verma, Y Deng, M Kocoglu, J Vasquez, ... Cancer Research 75 (15_Supplement), 1354-1354, 2015 | 1 | 2015 |
| Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy SJ Zhao, D Prior, CM Heske, JC Vasquez Cancers 16 (9), 1648, 2024 | | 2024 |
